These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38306629)

  • 1. Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.
    Kastango ES; Douglass K; Patel K; Givehchi B; Brister P; Postlewaite J; Taraban L
    Int J Pharm Compd; 2024; 28(1):44-55. PubMed ID: 38306629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAFER STERILE COMPOUNDING: Choosing and Using Disinfectants for the Cleanroom.
    Kastango ES; Douglass K; Patel K; Givehchi B; Brister P; Postlewaite J; Taraban L
    Int J Pharm Compd; 2015; 19(4):268-78. PubMed ID: 26625562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic Testing for 503A Sterile-Compounding Pharmacies.
    Mixon W; Roth A
    Int J Pharm Compd; 2017; 21(3):193-203. PubMed ID: 28557780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
    Allen LV
    Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is your cleanroom clean? An in-depth look at cleaning and disinfecting agents, procedures, and requirements for the compounding pharmacist.
    Jeffrey M
    Int J Pharm Compd; 2006; 10(2):113-9. PubMed ID: 23974185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depyrogenation options for the compounding cleanroom.
    Weller T; Bell J; Dullinger R; Allen V; Anthenat B
    Int J Pharm Compd; 2014; 18(6):446-54. PubMed ID: 25906620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disinfecting procedures for aseptic transfer in hospital pharmacy departments.
    Mehmi M; Marshall LJ; Lambert PA; Smith JC
    PDA J Pharm Sci Technol; 2009; 63(2):123-38. PubMed ID: 19634351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
    Hung JC; Anderson MM
    J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survey of methods of cleaning, decontamination, disinfection and sterilization in dental health services in tropical areas].
    Clapeau G; Decroix B; Bakayoko-Ly R; Varenne B; Dosso-Hien D; Decroix MO
    Sante; 1997; 7(5):323-9. PubMed ID: 9480039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expecting the Expected: Planning Considerations for Cleanroom Construction.
    Roberts PA; Kroon L
    Int J Pharm Compd; 2021; 25(4):276-281. PubMed ID: 34297688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compounding compliance team at an academic medical center.
    Chaffee BW; Tharp JC; Clark JS; Kent S
    Am J Health Syst Pharm; 2020 May; 77(11):882-891. PubMed ID: 32318700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Transducer Hygiene sufficient when Vaginal Probes are used in the Clinical Routine?
    Merz E
    Ultraschall Med; 2016 Apr; 37(2):137-9. PubMed ID: 27058433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrier isolators as an alternative to a cleanroom.
    Tillett L
    Am J Health Syst Pharm; 1999 Jul; 56(14):1433-6. PubMed ID: 10428451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.